These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6151847)

  • 21. Triazolam concentration-effect relationships in healthy subjects.
    Baktir G; Fisch HU; Huguenin P; Bircher J
    Clin Pharmacol Ther; 1983 Aug; 34(2):195-201. PubMed ID: 6135525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability.
    Evans SM; Funderburk FR; Griffiths RR
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1246-55. PubMed ID: 2262904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of triazolam and nitrazepam on sleep quality, morning vigilance and psychomotor performance.
    Hindmarch I; Clyde CA
    Arzneimittelforschung; 1980; 30(7):1163-6. PubMed ID: 6106500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relative abuse liability of GHB in humans: A comparison of psychomotor, subjective, and cognitive effects of supratherapeutic doses of triazolam, pentobarbital, and GHB.
    Carter LP; Richards BD; Mintzer MZ; Griffiths RR
    Neuropsychopharmacology; 2006 Nov; 31(11):2537-51. PubMed ID: 16880774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age-related increase in CNS sensitivity to benzodiazepines as assessed by task difficulty.
    Nikaido AM; Ellinwood EH; Heatherly DG; Gupta SK
    Psychopharmacology (Berl); 1990; 100(1):90-7. PubMed ID: 1967500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of two benzodiazepine hypnotics administered with alcohol.
    Hill SY; Goodwin DW; Reichman JB; Mendelson WB; Hopper S
    J Clin Psychiatry; 1982 Oct; 43(10):408-10. PubMed ID: 6126474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response to, "Cognitive, psychomotor and subjective effects of sodium oxybate and triazolam in healthy volunteers," 2009; 206(1):141-154.
    Zvosec DL; Smith SW
    Psychopharmacology (Berl); 2009 Dec; 207(3):509-10; author reply 511-2. PubMed ID: 19777215
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of the effects of zolpidem and triazolam on memory functions, psychomotor performances, and postural sway in healthy subjects.
    Berlin I; Warot D; Hergueta T; Molinier P; Bagot C; Puech AJ
    J Clin Psychopharmacol; 1993 Apr; 13(2):100-6. PubMed ID: 8463441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relative abuse liability of indiplon and triazolam in humans: a comparison of psychomotor, subjective, and cognitive effects.
    Carter LP; Griffiths RR; Suess PE; Casada JH; Wallace CL; Roache JD
    J Pharmacol Exp Ther; 2007 Aug; 322(2):749-59. PubMed ID: 17502431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Actions and interactions of hypnotics on human performance: single doses of zopiclone, triazolam and alcohol.
    Kuitunen T; Mattila MJ; Seppala T
    Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():115-30. PubMed ID: 2201724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative pharmacodynamics of benzodiazepines.
    Ellinwood EH; Nikaido AM; Heatherly DG
    Psychopharmacol Ser; 1987; 3():77-82. PubMed ID: 2881294
    [No Abstract]   [Full Text] [Related]  

  • 32. Sensitivity to triazolam in the elderly.
    Greenblatt DJ; Harmatz JS; Shapiro L; Engelhardt N; Gouthro TA; Shader RI
    N Engl J Med; 1991 Jun; 324(24):1691-8. PubMed ID: 2034245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of acute treatment with ramelteon, triazolam, and placebo on driving performance, cognitive function, and equilibrium function in healthy volunteers.
    Miyata A; Iwamoto K; Kawano N; Kohmura K; Yamamoto M; Aleksic B; Ebe K; Noda A; Noda Y; Iritani S; Ozaki N
    Psychopharmacology (Berl); 2015 Jun; 232(12):2127-37. PubMed ID: 25533998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective effects of triazolam on memory.
    Weingartner HJ; Hommer D; Lister RG; Thompson K; Wolkowitz O
    Psychopharmacology (Berl); 1992; 106(3):341-5. PubMed ID: 1570380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Midazolam and triazolam: hypnotic action and residual effects after a single bedtime dose.
    Borbély AA; Loepfe M; Mattmann P; Tobler I
    Arzneimittelforschung; 1983; 33(10):1500-2. PubMed ID: 6140018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triazolam: a review of its pharmacological properties and therapeutic efficacy in patients with insomnia.
    Pakes GE; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1981 Aug; 22(2):81-110. PubMed ID: 6114852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychometric performance during withdrawal from long-term benzodiazepine treatment.
    Petursson H; Gudjonsson GH; Lader MH
    Psychopharmacology (Berl); 1983; 81(4):345-9. PubMed ID: 6140702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychophysiological effects and dose equivalence of zopiclone and triazolam administered to healthy volunteers. Methodological considerations.
    Gorenstein C; Tavares SM; Gentil V; Peres C; Moreno RA; Dreyfus JF
    Braz J Med Biol Res; 1990; 23(10):941-51. PubMed ID: 2101059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Triazolam and ethanol interaction: kinetic and dynamic consequences.
    Dorian P; Sellers EM; Kaplan HL; Hamilton C; Greenblatt DJ; Abernethy D
    Clin Pharmacol Ther; 1985 May; 37(5):558-62. PubMed ID: 2859136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of psychomotor performance after intravenous and rectal diazepam.
    Jensen HH; Hansen HC; Drenck NE
    Anesth Prog; 1997; 44(1):5-10. PubMed ID: 9481974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.